Clover Health Investments (CLOV) Competitors $3.23 +0.04 (+1.25%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLOV vs. ESNT, FG, ACT, BWIN, GSHD, HGTY, OSCR, LMND, NMIH, and PLMRShould you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Essent Group (ESNT), F&G Annuities & Life (FG), Enact (ACT), The Baldwin Insurance Group (BWIN), Goosehead Insurance (GSHD), Hagerty (HGTY), Oscar Health (OSCR), Lemonade (LMND), NMI (NMIH), and Palomar (PLMR). These companies are all part of the "insurance" industry. Clover Health Investments vs. Essent Group F&G Annuities & Life Enact The Baldwin Insurance Group Goosehead Insurance Hagerty Oscar Health Lemonade NMI Palomar Clover Health Investments (NASDAQ:CLOV) and Essent Group (NYSE:ESNT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations. Does the MarketBeat Community favor CLOV or ESNT? Essent Group received 418 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 65.48% of users gave Essent Group an outperform vote while only 40.00% of users gave Clover Health Investments an outperform vote. CompanyUnderperformOutperformClover Health InvestmentsOutperform Votes2240.00% Underperform Votes3360.00% Essent GroupOutperform Votes44065.48% Underperform Votes23234.52% Is CLOV or ESNT more profitable? Essent Group has a net margin of 60.15% compared to Clover Health Investments' net margin of -5.92%. Essent Group's return on equity of 13.81% beat Clover Health Investments' return on equity.Company Net Margins Return on Equity Return on Assets Clover Health Investments-5.92% -25.46% -12.35% Essent Group 60.15%13.81%10.99% Do analysts recommend CLOV or ESNT? Clover Health Investments currently has a consensus target price of $5.00, suggesting a potential upside of 54.80%. Essent Group has a consensus target price of $64.71, suggesting a potential upside of 21.51%. Given Clover Health Investments' higher probable upside, equities research analysts plainly believe Clover Health Investments is more favorable than Essent Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Essent Group 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Do insiders & institutionals believe in CLOV or ESNT? 19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 93.0% of Essent Group shares are owned by institutional investors. 22.3% of Clover Health Investments shares are owned by company insiders. Comparatively, 2.9% of Essent Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer CLOV or ESNT? In the previous week, Clover Health Investments had 4 more articles in the media than Essent Group. MarketBeat recorded 10 mentions for Clover Health Investments and 6 mentions for Essent Group. Essent Group's average media sentiment score of 1.68 beat Clover Health Investments' score of 0.74 indicating that Essent Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Essent Group 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation & earnings, CLOV or ESNT? Essent Group has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Essent Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClover Health Investments$2.12B0.76-$213.36M-$0.20-16.15Essent Group$1.23B4.62$696.39M$6.907.72 Which has more volatility and risk, CLOV or ESNT? Clover Health Investments has a beta of 1.94, suggesting that its stock price is 94% more volatile than the S&P 500. Comparatively, Essent Group has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. SummaryEssent Group beats Clover Health Investments on 13 of the 18 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Clover Health Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLOV vs. The Competition Export to ExcelMetricClover Health InvestmentsHospital & medical service plans IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.62B$59.06B$5.13B$9.07BDividend YieldN/A1.78%5.08%4.23%P/E Ratio-16.1519.8789.5817.17Price / Sales0.760.561,116.12116.95Price / CashN/A8.8842.8237.86Price / Book5.474.504.774.78Net Income-$213.36M$3.04B$120.15M$225.60M7 Day Performance3.86%-6.51%-1.92%-1.23%1 Month Performance-4.30%-11.85%11.47%3.36%1 Year Performance229.59%20.93%30.54%16.60% Clover Health Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLOVClover Health Investments3.199 of 5 stars$3.23+1.3%$5.00+54.8%+229.6%$1.62B$2.12B-16.15552Analyst ForecastESNTEssent Group4.601 of 5 stars$55.79+1.1%$64.71+16.0%+2.3%$5.93B$1.11B8.00350Positive NewsFGF&G Annuities & Life2.4139 of 5 stars$44.59-0.1%$46.33+3.9%-9.4%$5.62B$5.50B-743.001,165Ex-DividendNews CoverageACTEnactN/A$34.47+0.4%$35.00+1.5%+13.3%$5.29B$1.20B8.03500BWINThe Baldwin Insurance Group2.8033 of 5 stars$40.91-0.1%$46.83+14.5%N/A$4.81B$1.33B-63.753,927News CoverageGSHDGoosehead Insurance3.44 of 5 stars$114.68-0.5%$97.90-14.6%+39.4%$4.26B$283.60M159.641,415Positive NewsHGTYHagerty2.2588 of 5 stars$11.01-0.7%$11.00-0.1%+29.2%$3.76B$1.16B100.821,732OSCROscar Health2.8632 of 5 stars$13.78+0.9%$21.56+56.5%+74.8%$3.41B$5.86B0.002,400LMNDLemonade3.1126 of 5 stars$44.43+6.0%$30.43-31.5%+146.1%$3.17B$493.20M-14.461,258Insider TradeNMIHNMI3.7731 of 5 stars$38.42+1.2%$43.14+12.3%+24.4%$3.04B$579M8.69234Positive NewsPLMRPalomar2.2878 of 5 stars$111.90+2.0%$111.67-0.2%+80.9%$2.96B$375.93M26.05150Insider TradePositive News Related Companies and Tools Related Companies Essent Group Alternatives F&G Annuities & Life Alternatives Enact Alternatives The Baldwin Insurance Group Alternatives Goosehead Insurance Alternatives Hagerty Alternatives Oscar Health Alternatives Lemonade Alternatives NMI Alternatives Palomar Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLOV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
